Uterine Cervical Neoplasms
📧 Sign up to get email alerts when something new happens for Uterine Cervical Neoplasms.
Sign up freeTop drugs studied for this disease
-
EMA approval · 2026-07-07EMA Authorised: Abevmy (bevacizumab) — Biosimilar Collaborations Ireland Limited
EMA authorises a biosimilar version of bevacizumab (Abevmy) for multiple cancer indications, expanding access to this biologic therapy.
-
EMA approval · 2026-06-05EMA Authorised: Tivdak (tisotumab vedotin) — Genmab A/S
EMA authorised Tivdak (tisotumab vedotin) for uterine cervical neoplasms, expanding treatment options in this indication.
-
EMA approval · 2026-03-31EMA Authorised: Topotecan Hospira (topotecan) — Pfizer Europe MA EEIG
EMA authorised Topotecan Hospira for use in small cell lung cancer and uterine cervical neoplasms.
-
EMA approval · 2026-02-24EMA Authorised: Tivdak (tisotumab vedotin) — Genmab A/S
The European Medicines Agency authorised Tivdak (tisotumab vedotin) for uterine cervical neoplasms, with Genmab A/S as the marketing authori…
-
CLINICAL_TRIALS research · 2025-10-02Clinical Trial Update: Post-TRaUmatic STress Disorder Induced by Gynecological Brachytherapy
This clinical trial update describes a study investigating post-traumatic stress disorder-like effects induced by gynecological brachytherap…
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2025-08-14Clinical Trial Update: MK-7684A With or Without Other Anticancer Therapies in Participants With Selected Solid Tumors (MK-7684A-005) (KEYVIBE-005) [Phase 2]
Merck completed a Phase 2 trial (MK-7684A-005) evaluating MK-7684A with or without other anticancer therapies in selected solid tumors.
-
CLINICAL_TRIALS research · 2024-07-05Clinical Trial Update: Epidemiological Landscape of Cervical Cancer in Latin America
This document summarizes an ongoing observational trial on the epidemiology of cervical cancer in Latin America, currently active but not re…
-
CLINICAL_TRIALS trial_result · 2023-11-24Clinical Trial Update: Tislelizumab Combined With Concurrent Chemoradiotherapy for Locally Advanced Cervical Cancer [Phase 2]
Phase 2 trial update exploring tislelizumab with concurrent chemoradiotherapy for locally advanced cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-07-06Clinical Trial Update: Evaluate the Effect of ReSpace™ Hydrogel on Reducing Rectal Radiation Dose in Radiotherapy for Cervical Cancer [Phase 2]
Phase 2 clinical trial evaluating ReSpace™ Hydrogel to reduce rectal radiation dose during radiotherapy for cervical cancer.
-
CLINICAL_TRIALS trial_result · 2023-05-09Clinical Trial Update: Bintrafusp Alfa Monotherapy in Platinum-Experienced Cervical Cancer [Phase 2]
Phase 2 trial update for bintrafusp alfa monotherapy in platinum-experienced cervical cancer (uterine cervical neoplasms) with completed sta…
-
CLINICAL_TRIALS trial_result · 2022-10-12Clinical Trial Update: Safety and Tolerability Evaluation Study of BVAC-C in Patients With HPV Type 16 or 18 Positive Cervical Cancer [Phase 1, Phase 2]
Clinical trial update on BVAC-C evaluating safety and tolerability in HPV16/18-positive cervical cancer (Phase 1/Phase 2) completed.
-
CLINICAL_TRIALS trial_result · 2022-02-10Clinical Trial Update: H101 Combined With Camrelizumab for Recurrent Cervical Cancer [Phase 2]
A Phase 2 clinical trial evaluating H101 in combination with camrelizumab for recurrent cervical cancer is reported as ongoing with status u…
-
CLINICAL_TRIALS trial_result · 2021-12-28Clinical Trial Update: A Study of Sintilimab Combined With Concurrent Chemoradiation Therapy in Locally Advanced Cervical Cancer [Phase 2]
A Phase 2 clinical trial evaluating sintilimab in combination with concurrent chemoradiation therapy for locally advanced cervical cancer.
-
CLINICAL_TRIALS trial_result · 2021-12-08Clinical Trial Update: E7 TCR T Cell Induction Immunotherapy for Stage IIB-IVA Cervical Cancer [EARLY_Phase 1]
Early-phase trial evaluating E7 TCR T cell induction immunotherapy for stage IIB-IVA cervical cancer; trial terminated with results posted.
-
CLINICAL_TRIALS trial_result · 2021-05-05Clinical Trial Update: Intended Use Study of the BD SurePath Plus™ Pap
Clinical trial update for the intended use study of the BD SurePath Plus Pap; the study is terminated with results posted in 2021.
-
CLINICAL_TRIALS trial_result · 2021-04-21Clinical Trial Update: The Potential for Metformin to Improve Tumor Oxygenation in Locally Advanced Cervix Cancer: A Phase II Randomized Trial [Phase 2]
A Phase II randomized trial explored metformin to improve tumor oxygenation in locally advanced cervical cancer, with completion reported.
-
CLINICAL_TRIALS trial_result · 2021-02-02Clinical Trial Update: Clinical Efficacy of Adjuvant Chemotherapy in Patients With Locally Advanced Cervical Cancer Who Did Not Meet the NCCN Guidelines for Adjuvant Treatment After NACT Combined With Surgery [Phase 3]
A Phase 3 clinical trial is evaluating the efficacy of adjuvant chemotherapy in locally advanced cervical cancer patients who did not meet N…
-
CLINICAL_TRIALS trial_result · 2020-02-05Clinical Trial Update: Safety and Immunogenicity Study of V503 (GARDASIL™9, 9vHPV Vaccine) Administered to 9- to 26-Year-Old Females and Males in Vietnam (V503-017) [Phase 3]
Phase 3 safety and immunogenicity study of GARDASIL 9 (V503) in 9- to 26-year-old females and males in Vietnam has completed enrollment with…
-
CLINICAL_TRIALS trial_result · 2019-09-20Clinical Trial Update: Combination of PD-1 Monoclonal Antibody and HPV Vaccine in Patients With Cervical Cancer [Phase 2]
Phase 2 trial updating combination therapy of a PD-1 monoclonal antibody with an HPV vaccine for cervical cancer.
-
EMA withdrawal · 2019-03-07EMA Withdrawn: Topotecan Actavis (topotecan) — Actavis Group PTC ehf
EMA withdrawn topotecan (Topotecan Actavis) indicated for uterine cervical neoplasms and small cell lung carcinoma; product withdrawn by MAH…
-
CLINICAL_TRIALS trial_result · 2018-08-14Clinical Trial Update: Postoperative Concurrent Chemoradiotherapy Combined With Endostar for High-risk Early Stage Cervical Cancer [Phase 2]
Phase 2 trial update investigating postoperative concurrent chemoradiotherapy combined with Endostar for high-risk early-stage cervical canc…
-
EMA withdrawal · 2018-07-27EMA Application withdrawn: Raligize — FGK Representative Service GmbH
The EMA withdrew the application for Raligize (FGK Representative Service GmbH) with a stated therapeutic area of uterine cervical neoplasms…
-
EMA withdrawal · 2018-07-13EMA Withdrawn: Topotecan Teva (topotecan) — Teva B.V.
Topotecan Teva has been withdrawn from the market by Teva B.V., affecting indications in ovarian neoplasms, uterine cervical neoplasms, and …
-
CLINICAL_TRIALS trial_result · 2018-04-18Clinical Trial Update: Clinical Evaluation of the BD Onclarity™ HPV Assay on the BD Viper™ LT System With Cervical Specimens [NA]
Clinical evaluation of the BD Onclarity HPV assay on the BD Viper LT system using cervical specimens has completed, with results posted in 2…
-
CLINICAL_TRIALS trial_result · 2017-09-05Clinical Trial Update: [F-18] Fluorothymidine PET/CT Imaging for Pelvic Cancers [Phase 2]
Phase 2 clinical trial update for [F-18] Fluorothymidine PET/CT imaging in pelvic cancers has completed; results posted in 2017.